|
06 Sep 2025 |
PI Industries
|
Consensus Share Price Target
|
3664.00 |
4061.68 |
- |
10.85 |
hold
|
|
|
|
|
25 Aug 2025
|
PI Industries
|
Keynote Capitals Ltd
|
3664.00
|
4142.00
|
3896.20
(-5.96%)
|
13.05 |
Neutral
|
|
|
Quarterly Update Q1FY26
|
|
22 Aug 2025
|
PI Industries
|
Deven Choksey
|
3664.00
|
4330.00
|
3865.10
(-5.20%)
|
18.18 |
Accumulate
|
|
|
We have revised our FY26E/FY27E EPS estimates by -4.4%/-9.0% factoring in a miss in Q1FY26 performance, slower-than-expected recovery in exports due to prolonged customer destocking, and regulatory headwinds in biologicals that have curtailed domestic growth.
|
|
14 Aug 2025
|
PI Industries
|
Axis Direct
|
3664.00
|
3930.00
|
3690.20
(-0.71%)
|
7.26 |
Hold
|
|
|
We downgrade our rating from BUY to HOLD on the stock as the challenges are expected to continue in the near term, and we await clear signs of a sustained recovery.
|
|
04 Jun 2025
|
PI Industries
|
Emkay
|
3664.00
|
3650.00
|
3970.30
(-7.71%)
|
0.38 |
Sell
|
|
|
Kumiai Chemical Industry (Kumiai) has revised up its H1FY25 revenue guidance by ~9% to JPY96bn from JPY88bn, citing that net sales are expected to exceed the forecast due to advanced shipment to overseas markets in its Agchem business.
|
|
04 Jun 2025
|
PI Industries
|
Geojit BNP Paribas
|
3664.00
|
4070.00
|
3970.30
(-7.71%)
|
Target met |
Hold
|
|
|
*over or under performance to benchmark index PI Industries manufactures plant protection and specialty plant nutrient products and solutions under its agri-inputs business. It is also a leading custom synthesis and manufacturing (CSM) company in India, providing contract research and contract...
|
|
23 May 2025
|
PI Industries
|
Keynote Capitals Ltd
|
3664.00
|
4306.00
|
3680.80
(-0.46%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY25
|
|
10 Feb 2025
|
PI Industries
|
Axis Direct
|
3664.00
|
4265.00
|
3524.20
(3.97%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
18 Dec 2024
|
PI Industries
|
Geojit BNP Paribas
|
3664.00
|
4480.00
|
3884.30
(-5.67%)
|
22.27 |
Buy
|
|
|
|
|
21 Nov 2024
|
PI Industries
|
Keynote Capitals Ltd
|
3664.00
|
4722.00
|
4138.70
(-11.47%)
|
28.88 |
Buy
|
|
|
Quarterly Update Q2FY25
|
|
18 Nov 2024
|
PI Industries
|
Axis Direct
|
3664.00
|
4880.00
|
4191.95
(-12.59%)
|
33.19 |
Buy
|
|
|
We upgrade our rating on the stock from HOLD to BUY considering attractive valuations post the recent correction in stock price while long-term growth prospects remain intact.
|
|
18 Sep 2024
|
PI Industries
|
Axis Direct
|
3664.00
|
4980.00
|
4654.90
(-21.29%)
|
35.92 |
Hold
|
|
|
Based on our estimates, PI Industries is valued at 30x FY26E, with a target price of Rs 4,980 per share. This implies an upside potential of 6% from the CMP, with a HOLD recommendation.
|
|
12 Aug 2024
|
PI Industries
|
Keynote Capitals Ltd
|
3664.00
|
4722.00
|
4441.00
(-17.50%)
|
Target met |
Neutral
|
|
|
Quarterly Update Q1FY25
|
|
09 Aug 2024
|
PI Industries
|
Axis Direct
|
3664.00
|
4980.00
|
4487.70
(-18.35%)
|
|
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
08 Aug 2024
|
PI Industries
|
Sharekhan
|
3664.00
|
5049.00
|
4457.25
(-17.80%)
|
|
Buy
|
|
|
PI Industries’ (PI) revenue for the quarter reached Rs. 2,069 crore, reflecting an 8% y-o-y increase and a 19% q-o-q rise, 2% above expectations.
|
|
27 Jun 2024
|
PI Industries
|
Sharekhan
|
3664.00
|
4400.00
|
3819.55
(-4.07%)
|
Target met |
Buy
|
|
|
PI Industries has offered to acquire UK based listed company Plant Health Care Plc (PHC) for a sum of £32.8 million which is in the agriculture biological space. It has experience in protein/peptide technology.
|
|
29 May 2024
|
PI Industries
|
Geojit BNP Paribas
|
3664.00
|
4180.00
|
3578.55
(2.39%)
|
Target met |
Buy
|
|
|
|
|
24 May 2024
|
PI Industries
|
Axis Direct
|
3664.00
|
4220.00
|
3630.90
(0.91%)
|
Target met |
Buy
|
|
|
we maintain our BUY rating on the stock.
|
|
24 May 2024
|
PI Industries
|
Keynote Capitals Ltd
|
3664.00
|
4319.00
|
3630.90
(0.91%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY24
|
|
23 May 2024
|
PI Industries
|
Motilal Oswal
|
3664.00
|
4280.00
|
3659.50
(0.12%)
|
Target met |
Buy
|
|
|
PI Industries (PI)’s revenue grew 11% YoY in 4QFY24, led by a healthy growth in the CSM business (up 9% YoY) and incremental revenue from the Pharma business, which was absent in 4QFY23 (revenue mix of ~4% in 4QFY24).
|
|
22 Mar 2024
|
PI Industries
|
Anand Rathi
|
3664.00
|
4600.00
|
3834.90
(-4.46%)
|
Target met |
Buy
|
|
|
|